Stanford researchers have developed a scalable method for producing precisely engineered 3D-printed lattice structures for inertial confinement fusion targets. Current fusion target materials often use porous foams to hold and distribute fusion fuel.
Continuous positive airway pressure (CPAP) therapy is currently the first line non-surgical treatment when a patient is diagnosed with obstructive sleep apnea (OSA).
Researchers from Stanford University and the Technical University of Munich (TUM) propose a new approach for treating Type 2 Diabetes (T2D) by targeting the cathelicidin gene expression pathway.
Researchers at Stanford University have found that upregulating cathelicidin gene expression can improve the efficacy of a wide variety of treatments as an adjunct therapy.
Huntington's Disease and other ataxias are devastating diseases without any cure or treatment. They are caused by the formation of toxic oligomeric and the aggregation of the Huntintin (HTT) protein.
Researchers at Stanford have developed an IL-7–conjugated lipid nanoparticle (LNP) platform designed to substantially improve mRNA delivery to T cells for direct in vivo T-cell engineering.
Stanford researchers have developed a next-generation programmable transcriptional activation platform, TIGRa, that addresses key limitations of CRISPRa technologies, including large size, limited multiplexing capacity, and delivery constraints.
Researchers at Stanford have designed, in silico, a series of new human IL-2 mutants that have biased actions on different immune cell subsets, and confer increased signaling potency compared to natural IL-2.
Stanford researchers have developed Microbe-Independent Deep Assembly and Screening (MIDAS-M), a novel platform that dramatically accelerates the cloning of protein variants and its analysis in mammalian cells.
Stanford scientists have developed a thin, wearable electrode array patch capable of non-invasively recording high-resolution electrical signals through the skin of the body's internal organs, offering a new window into physiological processes that have historically been diffi
Imaging methods that can visualize biological samples with high and temporal resolution are critical for modern biomedical research and clinical practice.
Stanford researchers have developed a personalized arrhythmia risk prediction tool for dilated cardiomyopathy (DCM) patients using patient-derived induced pluripotent stem cells (iPSCs) to replicate heart biology and accurately predict arrhythmia risk, enabling timely interven
Researchers in Prof. Mark Schnitzer's laboratory have developed a robotic optical microscopy system which enables users to simultaneously view and record separate areas of a single three-dimensional sample.
Stanford scientists have discovered novel high molecular weight isoforms of thymic stromal lymphopoietin (TSLP), measured using nanoimmunoassay (NIA), that can serve as a blood-based biomarker for the diagnosis and prognostication of acute graft versus host disease (aGVHD).